NIAID

10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical...

09-18-2024NIH s National Institute of Allergy and Infectious Diseases has recently shared news about mpox research, HIV risk among cisgender women, COVID in people with..…

09-11-2024Cross-posted from: NIAID Now NIAID Researchers Uncover How SARS-CoV-2 Variants May Emerge in People with Weak...

08-15-2024A brief roundup of key topics of HIV.gov s coverage of AIDS 2024, including HIV prevention, cure research, and more.

08-01-2024Cross-posted from: NIDA blog For complex reasons, HIV and substance use have been inextricably linked since the...

07-26-2024Kaye Hayes, HHS Deputy Assistant Secretary for Infectious Disease and Director of the Office of Infectious Disease and HIV/AIDS Policy, and Francisco Ruiz, Dire…

07-26-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (teal) budding and...

07-25-2024HIV.gov continues its daily livestreams from the International AIDS Conference in Munich, Germany. Today s topics include long-acting injectables, bi-directio..…

07-25-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (green) replicatin...

07-24-2024Read updates about HIV.gov s conversations on day three of the International AIDS Conference in Munich, Germany.

07-23-2024Watch HIV.gov s conversations on the second day of the International AIDS Conference in Munich, Germany.

07-23-2024Colorized transmission electron micrograph of multiple HIV-1 virus particles (green) budding from a cell projec...

06-28-2024Cross-posted from: NIAID Now Blog The power of word choice is obvious every day in my life as a researcher, c...

06-07-2024Cross-posted from NIAID Newsroom Colorized transmission electron micrograph of numerous HIV-1 virus particles...

06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and treat…

06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for health...

05-17-2024Cross-posted from: NIAID Now Vaccines consistently transform public health, and HIV vaccine research has been...

05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.…

05-14-2024Resources to highlight HIV Vaccine Awareness Day on May 18, a day to recognize the community members, health professionals, and scientists working together to d…

04-24-2024Cross-posted from: NIAID Now Blog The HIV research community is led by scientists with deep personal commitments to improving the lives of people with and affe.…